Friday 6 November 2026
Export ASPN’s income statement to Excel — free account
Aspen Aerogels, Inc.
ASPN Basic Materials Specialty Chemicals
Aspen Aerogels, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $271.1 million, down 40.1% from fiscal 2024.
- Revenue
- +16.7%
- EPS
- −62.5%
- Free cash flow
- −93.1%
- Total debt
- −79.6%
Quarter to September 2026, against a year earlier
4.90
0.26
−5.04%
Follow ASPN
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 4 | 4 |
+8 more TTM periods Free account |
| (53.16%) | (50.36%) | (42.40%) | (91.64%) | ||
| (29.43%) | (27.49%) | (23.20%) | (59.85%) | ||
ROIC |
(131.54%) | (58.13%) | (47.78%) | (126.54%) | |
Return on Tangible Assets |
(59.95%) | (54.06%) | (43.09%) | (139.91%) | |
Average Days of Receivables |
106.05 | 72.75 | 57.76 | 47.49 | |
Free Cash Flow per Share |
0.35 | 0.41 | 0.43 | (0.06) | |
Free Cash Flow |
28.86 | 34.38 | 35.57 | (4.58) | |
Capital Expenditures |
(1.47) | (14.73) | (25.82) | (37.45) | |
| Other line items | |||||
Cash ROIC |
8.17% | 7.82% | 7.38% | (0.91%) | |
Accounts Receivable Turnover |
3.26 | 3.47 | 4.05 | 3.76 | |
Accounts Payable Turnover |
7.43 | 8.20 | 7.58 | 7.82 | |
Inventory Turnover |
5.78 | 4.91 | 4.62 | 5.25 | |
Average Days of Payables |
64.92 | 38.89 | 24.50 | 21.47 | |
Days of Inventory on Hand |
51.16 | 51.87 | 55.89 | 62.02 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
5.22% | 5.55% | 5.13% | 4.95% | |
Selling, General and Administrative Expense of Revenue |
39.29% | 41.40% | 36.70% | 30.97% | |
Share Based Compensation of Revenue |
3.29% | 3.76% | 3.71% | 3.18% | |
Interest Coverage |
— | (10.30) | (8.93) | — | |
Operating CF/Net income |
(0.23) | (0.39) | (0.55) | (0.08) | |
Depreciation/Fixed assets |
0.00 | 0.58 | 0.53 | 0.50 | |
Capex/Depreciation |
0.00 | (0.30) | (0.52) | (0.77) | |
Revenue per Share |
2.58 | 2.44 | 2.78 | 3.29 | |
Operating CF per Share |
0.37 | 0.59 | 0.74 | 0.40 | |
Capex per Share |
(0.02) | (0.18) | (0.31) | (0.45) | |
Capex to Sales |
0.01 | 0.07 | 0.11 | 0.14 |
Columns are period end dates · fundamentals updated 5 Nov 2026